Levo Therapeutics, Inc.

Calculating rank

USPTO Granted Patents = 5

EPO Patents = 1

Trademarks = 6

Forward Citations = 2

Loading Chart...

9 inventors (with patents filed for the assignee):

Mark Cornell Manning (3 out of 85 patents)

Ryan Erik Holcomb (3 out of 15 patents)

Christopher Bryant (3 out of 4 patents)

4. Sara Cotter (3 out of 3 patents)

5. Lisa Cole Burnett (2 out of 2 patents)

6. Dieter Egli (2 out of 2 patents)

7. Rudolph L Leibel (2 out of 4 patents)

8. Joseph William Cormier (1 out of 1 patent)

9. Derrick Spencer Katayama (1 out of 2 patents)

5 patents: Sort by Forward Citations

1. 11957656 - Methods of treating Prader-Willi syndrome (2024-04-16),

2. 11298399 - Carbetocin drug product and process for preparing same (2022-04-12),

3. 11207373 - Agitation process for preparing a carbetocin drug product (2021-12-28),

4. 10967040 - Methods of treating prader-willi syndrome with carbetocin (2021-04-06),

5. 10842775 - Methods of treating Prader-Willi syndrome (2020-11-24),

Company Overview

Levo Therapeutics, Inc. is a biopharmaceutical company focused on developing treatments for central nervous system disorders, with an initial focus on Prader-Willi syndrome. Their innovative approach aims to address the underlying causes of these disorders to improve patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

5 Patents

#48 in Skokie, IL

#2,427 in Illinois

#51,669 in US

Skokie, IL, United States of America

Levo Therapeutics, Inc.

Forward Citations = 2

9 inventors:

Mark Cornell Manning (3 out of 85 patents)

Ryan Erik Holcomb (3 out of 15 patents)

Christopher Bryant (3 out of 4 patents)

4. Sara Cotter (3 out of 3 patents)

5. Lisa Cole Burnett (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Levo Therapeutics, Inc.. Retrieved from https://idiyas.com/company/levo-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]